Contemporary Issues in Pharmaceutical Patent Law

Setting the Framework and Exploring Policy Options
Herausgeber: Kim, Daria; Mercurio, Bryan

• Broschiertes Buch

Produktbeschreibung

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Routledge Research in Intellectual Property
• Verlag: Taylor & Francis Ltd
• Seitenzahl: 260
• Erscheinungstermin: 8. Januar 2019
• Englisch
• Abmessung: 234mm x 156mm x 14mm
• Gewicht: 408g
• ISBN-13: 9780367193386
• ISBN-10: 0367193388
• Artikelnr.: 56922721

Autorenporträt

Bryan Mercurio is Professor and Vice Chancellor's Outstanding Fellow of the Faculty of Law at the Chinese University of Hong Kong. Daria Kim is Doktorandin at the Max Planck Institute for Innovation and Competition.

Inhaltsangabe

1. Introduction: A Holistic Approach to Pharmaceutical Patent Law and
Policy, Bryan Mercurio and Daria Kim Part 1: Pharmaceutical Patents and
Related Types of Protection 2. Patentability of Pharmaceutical Inventions
under TRIPS: Domestic Court Practice Testing International Policy Space,
Roberto Romandini and Henning Grosse Ruse-Khan 3. Biologics, Biosimilars
and Other Idiosyncrasies, Yaniv Heled 4. Index of Data Exclusivity and
Access (IDEAS): An Analysis of Test Data Exclusivity Provisions in Free
Trade Agreements and National Laws, Owais Hassan Shaikh 5. Patent Linkage
Regulations: The Importance of Context and of Balancing Competing
Interests, Bryan Mercurio Part 2: Balancing Patent Protection with
Available Flexibilities 6. The Bolar Exception: Legislative Models and
Drafting Options, Carlos Correa 7. Compulsory Licensing: Threats, Use and
Recent Trends, Chang-fa Lo 8. A Manufacturing for Export Exception, Xavier
Seuba, Luis Mariano Genovesi and Pedro Roffe Part 3: A Broader View on
Incentives for Pharmaceutical Innovation 9. The Price of Exclusivity: The
Economics of Patent Extensions and Data Protection, Aidan Hollis and Paul
Grootendorst 10. Rationalizing Innovation Incentives under Drug Approval
Regulation: National Policy Perspective, Daria Kim 11. The Trans-Pacific
Partnership Agreement and Its Implications for Access to Medicine, Jakkrit
Kuanpoth